Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Glaucoma Topic Center

News
01/09/2020
A prescription ophthalmic solution used to reduce pressure inside the eye from glaucoma is being recalled.
A prescription ophthalmic solution used to reduce pressure inside the eye from glaucoma is being recalled.
A prescription ophthalmic...
01/09/2020
Pharmacy Learning Network
From Pharmacy Learning Network
Conference Insider
11/20/2019
When compared to prostaglandin analogs (PGA), latanoprostene bunod appears to be cost-saving in the treatment of primary open-angle glaucoma, according to data presented at AMCP Nexus 2019. 
When compared to prostaglandin analogs (PGA), latanoprostene bunod appears to be cost-saving in the treatment of primary open-angle glaucoma, according to data presented at AMCP Nexus 2019. 
When compared to prostaglandin...
11/20/2019
First Report Managed Care
From First Report Managed Care
News
05/08/2019
According to new research, increasing cholesterol levels may be associated with increased risk of primary open-angle glaucoma.
According to new research, increasing cholesterol levels may be associated with increased risk of primary open-angle glaucoma.
According to new research,...
05/08/2019
Pharmacy Learning Network
From Pharmacy Learning Network
News
04/26/2019
A recent study found that both health care resource utilization and costs are higher for patients with exfoliation glaucoma compared to patients with primary open-angle glaucoma.
A recent study found that both health care resource utilization and costs are higher for patients with exfoliation glaucoma compared to patients with primary open-angle glaucoma.
A recent study found that both...
04/26/2019
First Report Managed Care
From First Report Managed Care
News
02/28/2018
Increased daily intake of the polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid and docosahexaenoic acid are associated with a decreased risk of glaucoma, the results of a recent study show.
Increased daily intake of the polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid and docosahexaenoic acid are associated with a decreased risk of glaucoma, the results of a recent study show.
Increased daily intake of the...
02/28/2018
Pharmacy Learning Network
From Pharmacy Learning Network

Advertisement

Advertisement

Advertisement